Therapeutic activity of a new KRASG12C inhibitor JMKX001899 in brain metastases: Preclinical models of KRASG12C-mutant non-small cell lung cancer

被引：0
|
作者：
He, Danming
Wang, Jie
Zhu, Yixiang
Zhong, Jia
Bai, Hua
机构：
[1] Chinese Acad Med Sci, State Key Lab Mol Oncol, CAMS Key Lab Translat Res Lung Canc,Canc Hosp, Natl Canc Ctr,Natl Clin Res Ctr Canc,Dept Med Onc, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Dept Med Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Dept Med Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp,State Key Lab Mo, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8630
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Targeting KRASG12C in Non-Small-Cell Lung Cancer: Current Standards and Developments
    Torres-Jimenez, Javier
    Espinar, Javier Baena
    de Cabo, Helena Bote
    Berjaga, Maria Zurera
    Esteban-Villarrubia, Jorge
    Fraile, Jon Zugazagoitia
    Paz-Ares, Luis
    DRUGS, 2024, 84 (05) : 527 - 548
  • [42] Gene expression correlates of adagrasib response in KRASG12C mutated non-small cell lung cancer (NSCLC)
    Kim, Eejung
    Tong, Xinyuan
    Patel, Ayushi
    Liu, Shengwu
    Dilly, Julien
    Hover, Laura
    Mukhopadhyay, Suman
    Sherman, Fiona
    Christensen, James G.
    Olson, Peter
    Aguirre, Andrew
    Wong, Kwok
    Ji, Hongbin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [43] Combined inhibition of KRASG12C and mTORC1 kinase is synergistic in non-small cell lung cancer
    Kitai, Hidenori
    Choi, Philip H.
    Yang, Yu C.
    Boyer, Jacob A.
    Whaley, Adele
    Pancholi, Priya
    Thant, Claire
    Reiter, Jason
    Chen, Kevin
    Markov, Vladimir
    Taniguchi, Hirokazu
    Yamaguchi, Rui
    Ebi, Hiromichi
    Evans, James
    Jiang, Jingjing
    Lee, Bianca
    Wildes, David
    de Stanchina, Elisa
    Smith, Jacqueline A. M.
    Singh, Mallika
    Rosen, Neal
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [44] The selective WEE1 inhibitor azenosertib shows synergistic anti-tumor activity with KRASG12C inhibitors in multiple KRASG12C models
    Jameson, Nathan M.
    Kim, Gabriel
    Lee, Catherine
    Skrable, Blake
    Shea, Alexandra
    Abed, Monah
    Harismendy, Olivier
    Ma, Jianhui
    Kim, Doris
    Lackner, Mark R.
    CANCER RESEARCH, 2024, 84 (06)
  • [45] Rapid autopsy provides unique research opportunity to evaluate KRASG12C inhibitor resistance mechanisms in non-small cell lung cancer
    Ozakinci, Hilal
    Nazario, Gina
    Stern, Yaakov
    Solanki, Hitendra S.
    Chen, Dung-Tsa
    Trevor, Rose
    Schabath, Matthew
    Stewart, Paul
    Teer, Jamie K.
    Beg, Amer
    Boyle, Theresa A.
    Haura, Eric
    Pellini, Bruna
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [46] Adagrasib in KRYSTAL-12 has Broken the KRASG12C Enigma Code in Non-Small Cell Lung Carcinoma
    Luo, Faustine X.
    Arter, Zhaohui Liao
    LUNG CANCER-TARGETS AND THERAPY, 2024, 15 : 161 - 167
  • [47] CRISPR Screening Identifies Mechanisms of Resistance to KRASG12C and SHP2 Inhibitor Combinations in Non-Small Cell Lung Cancer
    Prahallad, Anirudh
    Weiss, Andreas
    Voshol, Hans
    Kerr, Grainne
    Sprouffske, Kathleen
    Yuan, Tina
    Ruddy, David
    Meistertzheim, Morgane
    Kazic-Legueux, Malika
    Kottarathil, Tina
    Piquet, Michelle
    Cao, Yichen
    Martinuzzi-Duboc, Laetitia
    Buhles, Alexandra
    Adler, Flavia
    Mannino, Salvatore
    Tordella, Luca
    Sansregret, Laurent
    Maira, Sauveur-Michel
    Graus Porta, Diana
    Fedele, Carmine
    Brachmann, Saskia M.
    CANCER RESEARCH, 2023, 83 (24) : 4130 - 4141
  • [48] Efficacy and toxicity of drugs targeting KRASG12C mutation in non-small cell lung cancer: a meta-analysis
    Luo, Wei
    Zhu, Jing
    Zhang, Wenxue
    Yu, Airu
    Zhou, Wei
    Xu, Ke
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (12) : 1295 - 1303
  • [49] KRASG12C mutation-induced TOPK overexpression contributes to tumour progression in non-small cell lung cancer
    Cai, Chang
    Yao, Shuo
    Zou, Yanmei
    Lu, Hui
    Chen, Xiuqiong
    Wang, Yali
    Zheng, Kun
    Zhu, Feng
    Wang, Yihua
    Xiong, Hua
    Zhu, Junfei
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2023, 27 (12) : 1637 - 1652
  • [50] Phase 1 Trial Evaluating Safety, Efficacy, and PK of AMG 510, a Novel KRASG12C Inhibitor, in Non-Small Cell Lung Cancer
    Govindan, R.
    Fakih, M. G.
    Price, T. J.
    Falchook, G. S.
    Desai, J.
    Kuo, J. C.
    Strickler, J. H.
    Krauss, J. C.
    Li, B. T.
    Denlinger, C. S.
    Durm, G.
    Ngang, J.
    Henary, H.
    Ngarmchamnanrith, G.
    Rasmussen, E.
    Morrow, P. K.
    Hong, D. S.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1191 - S1192
12345